Pfizer (PFE) Tops Q2 EPS by 11c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.80 -1.14%
Revenue Growth %: -4.6%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
TAYD, PKE, More
Revenue Growth %: -4.6%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $19 billion versus the consensus estimate of $18.45 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.95-$4.05, versus the consensus of $3.70. Pfizer sees FY2021 revenue of $78-80 billion, versus the consensus of $72.78 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
- Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance
- Integra LifeSciences stock tumbles after cutting 2026 outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
